Second cancers after chemotherapy: an honest look

Yes, although it is uncommon. A second cancer is a new, different cancer that develops after treatment for a first cancer. It is not the original cancer coming back. Some chemotherapy medicines and radiotherapy can damage the genetic material of healthy cells, and in a small number of people this leads to a new cancer years later. The risk is real and it is right to know about it, but for the great majority of people the benefit of treating the first cancer far outweighs this small added risk. Many second cancers are also linked to factors other than treatment, such as inherited genes, smoking, alcohol, ageing and the same lifestyle factors that contributed to the first cancer.

Certain treatments carry more risk than others. Alkylating medicines, such as cyclophosphamide, chlorambucil, melphalan and busulfan, and topoisomerase inhibitors, such as etoposide and doxorubicin, are linked with a small raised risk of blood cancers, particularly acute myeloid leukaemia and myelodysplastic syndrome. These usually appear within several years of treatment. Radiotherapy is linked with solid cancers in the area treated, such as breast cancer after chest radiotherapy for lymphoma in young women, or thyroid cancer after neck radiotherapy, and these usually appear a decade or more later. High-dose treatment with stem cell transplant, treatment in childhood, and combinations of chemotherapy and radiotherapy increase the risk further.

Knowing about this risk helps you stay alert rather than anxious. Keep your treatment records, follow any extra screening your team recommends, such as earlier breast screening after chest radiotherapy, attend follow-up, and report symptoms such as unusual bruising, repeated infections, extreme tiredness, new lumps or unexplained weight loss. Avoiding tobacco, limiting alcohol, protecting skin from the sun and keeping active reduce overall cancer risk. This page explains the general picture; your oncologist can discuss your own risk.

The risk is small but real

For most people, treatment benefit far outweighs it.

It depends on the treatment

Certain medicines and radiotherapy carry more risk.

Screening and habits help

Extra screening, healthy habits and reporting symptoms support early detection.

It cannot tell you your personal risk of a second cancer. That depends on your treatment, age, genes and lifestyle, and your oncologist can discuss it with you.

It also cannot give figures. Risks vary widely between treatments and people.

Second cancer or the first cancer returning?

A second cancer is a different type of cancer, while the first cancer returning means the same cancer has come back. Tests, including tissue samples, help doctors tell them apart. The distinction matters because treatment differs.

Inherited risk

Some people have inherited gene changes that raise the risk of several cancers. If you had cancer young, or several family members have had cancer, ask whether genetic counselling or testing is appropriate.

Modern treatment and lower risk

Treatment approaches have changed to reduce long-term risks, such as using smaller radiotherapy areas, lower doses where safe, and limiting certain medicines. People treated more recently may have lower risks than those treated decades ago.

Screening after chest radiotherapy

Women who had chest radiotherapy at a young age may be advised to start breast screening earlier than usual. Ask your team what applies to you.

Tobacco and second cancers

Smoking and chewing tobacco greatly increase the risk of many cancers, especially after lung, head and neck or bladder cancer. Stopping is one of the most effective protective steps.

Emotional impact

Learning about second cancer risk can be unsettling. Focusing on practical steps and support can help keep worry manageable.

Blood disorders after treatment

Myelodysplastic syndrome is a condition in which the bone marrow does not make healthy blood cells properly. It can occur after certain chemotherapy and sometimes progresses to acute myeloid leukaemia. Signs include tiredness, breathlessness, infections and bruising. Blood counts help detect it.

Skin cancers

Skin in areas that had radiotherapy, and skin in people with weakened immunity after transplant, may have a higher risk of skin cancers. Check your skin regularly and protect it from the sun.

Lung cancer after chest radiotherapy

People who had chest radiotherapy, especially smokers, have a higher risk of lung cancer later. Stopping smoking is essential, and a persistent cough or coughing blood should be reported.

Discussing risk without fear

It is reasonable to ask your oncologist how your treatment affects second cancer risk. Many people find that understanding the actual level of risk is less frightening than uncertainty.

Treatment of second cancers

Second cancers are treated according to their type and extent, taking into account previous treatment. Earlier treatments can limit some options, which is why treatment records matter.

Children and young adults

Survivors of childhood cancer benefit from lifelong follow-up that includes screening for second cancers based on their treatment.

Family history and screening

If cancers run in your family, tell your doctors, as screening or genetic testing plans may change.

Staying informed

Guidance on screening after cancer treatment evolves. Ask at follow-up whether any new recommendations apply.

Keeping records of radiotherapy areas

Radiotherapy areas are recorded by the radiotherapy department. Ask for a summary, as it guides future screening.

What to do next

Ask your oncologist about your risk and any extra screening, keep your treatment records, attend follow-up, avoid tobacco, limit alcohol, protect your skin, stay active, and report new symptoms promptly.